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Bacterial conjugation is a mechanism of horizontal DNA transfer. The relaxase 20 
TrwC of the conjugative plasmid R388 cleaves one strand of the transferred DNA at the 21 
oriT, covalently attaches to it and leads the ssDNA into the recipient cell. In addition, 22 
TrwC catalyzes site-specific integration of the transferred DNA into its target sequence 23 
present in the genome of the recipient bacterium. Here, we report the analysis of the 24 
efficiency and specificity of the integrase activity of TrwC in human cells, using the 25 
Type IV Secretion System of the human pathogen Bartonella henselae to introduce 26 
relaxase-DNA complexes. When compared to Mob relaxase from plasmid pBGR1, we 27 
found that TrwC mediated a 10-fold increase in the rate of plasmid DNA transfer to 28 
human cells, and a 100-fold increase in the rate of chromosomal integration of the 29 
transferred DNA. We used linear amplification-mediated PCR and plasmid rescue to 30 
characterize the integration pattern in the human genome. DNA sequence analysis 31 
revealed mostly reconstituted oriT sequences, indicating that TrwC is active and 32 
recircularizes transferred DNA in human cells. One TrwC-mediated site-specific 33 
integration event was detected, proving that TrwC is capable of mediating site-specific 34 
integration in the human genome, albeit with very low efficiency compared to the rate 35 
of random integration. Our results suggest that TrwC may stabilize the plasmid DNA 36 
molecules in the nucleus of the human cell, probably by recircularization of the 37 
transferred DNA strand. This stabilization would increase the opportunities for 38 







Different biotechnological applications, including gene therapy strategies, 44 
require permanent modification of target cells. Long-term expression is achieved 45 
either by extrachromosomal persistence or by integration of the introduced DNA. Here 46 
we study the utility of conjugative relaxase TrwC, a bacterial protein with site-specific 47 
integrase activity in bacteria, as integrase in human cells. Although not efficient as site-48 
specific integrase, we found that TrwC is active in human cells and promotes random 49 
integration of the transferred DNA in the human genome, probably acting as a DNA 50 
chaperone until it is integrated by host mechanisms. TrwC-DNA complexes can be 51 
delivered to human cells through a Type IV Secretion System involved in pathogenesis. 52 
Thus, TrwC could be used in vivo to transfer the DNA of interest into the appropriate 53 
cell and promote its integration. If used in combination with a site-specific nuclease, it 54 
could lead to site-specific integration of the incoming DNA by homologous 55 
recombination. 56 
 57 





Bacterial conjugation is an efficient mechanism of horizontal DNA transfer 61 
which confers bacteria an elevated level of genomic plasticity (1). DNA is transferred 62 
by conjugation from a donor to a recipient bacterium through a protein complex 63 
known as conjugative apparatus (2). In gram-negative bacteria, the conjugative 64 
machinery is composed of three functional modules (3): i) the relaxosome, a complex 65 
formed by the DNA to be transferred - in particular the site known as origin of transfer 66 
(oriT) - and the proteins responsible for DNA processing, which include a relaxase and 67 
one or more accessory proteins; ii) the Type IV Secretion System (T4SS), a multiprotein 68 
complex organized in a transmembranal conduit that spans both inner and outer 69 
membranes; and iii) the coupling protein (T4CP), a DNA-dependent ATPase which 70 
brings together the two previous components and is believed to play a crucial role in 71 
substrate selection. The translocated substrate is the relaxase covalently linked to the 72 
transferred DNA strand. 73 
 R388 is a conjugative plasmid of broad host range that belongs to the IncW 74 
incompatibility group (4). The 15 kb transfer region can be separated into an Mpf (for 75 
Mating pair formation) region, which encodes the T4SS apparatus, and a Dtr (for DNA 76 
transfer and replication) region encoding the T4CP and the relaxosome (5). The latter is 77 
composed of an oriT of 330 bp length, the relaxase TrwC, and two accessory proteins, 78 
the plasmid-encoded TrwA and the host-encoded integration host-factor (IHF) (6). 79 
During conjugation, TrwC binds to the oriT, cleaves the DNA strand to be transferred at 80 
the nic site, and makes a covalent bond with its 5´end (7). Then the relaxase-DNA 81 
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complex is recruited by the T4CP to the T4SS and transported to the recipient cell, 82 
where TrwC catalyzes the recircularization of the transferred DNA strand (8, 9). 83 
Apart from its role in conjugation, TrwC is able to catalyze site-specific 84 
recombination between two oriT copies repeated in tandem (10). The reaction takes 85 
place in the absence of conjugation, and thus in the absence of single stranded 86 
intermediates, and is favored by the accessory protein TrwA. In contrast, IHF was 87 
found to exert a negative regulatory role in TrwC-mediated recombination (11). It was 88 
proposed that recombination takes place thanks to the single-stranded endonuclease 89 
activity of TrwC coupled to the replication machinery of the host cell (10). 90 
Once transferred to the recipient cell during conjugation, TrwC can also 91 
catalyze site-specific integration of the transferred DNA strand into an oriT-containing 92 
plasmid in the recipient cells (8). In this case, both TrwA and IHF act as enhancers of 93 
the reaction. Integration also occurs when the acceptor oriT was located in the 94 
chromosomal DNA of the recipient cell (12). A minimal oriT core sequence of 17 bp is 95 
enough for TrwC to achieve integration. Two human sequences with one single 96 
mismatch to that minimal oriT were tested as acceptors for TrwC-mediated integration 97 
and found to be functional with an efficiency only 2-3 times lower than that obtained 98 
with the wild-type minimal oriT, indicating that TrwC can act on DNA sequences 99 
present in the human genome (12). 100 
 In addition to the T4SS involved in conjugative DNA transfer, there is another 101 
family of T4SS implicated in the secretion of effector proteins during the infection 102 
process of several mammalian and plant pathogens (13). Substrate recruitment by 103 
T4SS relies on secretion signals present in the protein substrate, and there are several 104 
examples of heterologous protein translocation by T4SS upon addition of secretion 105 
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signals. In particular, conjugative relaxases can be translocated into eukaryotic cells 106 
through T4SS of bacterial pathogens, either unmodified due to some similarity in their 107 
C-termini with the secretion signal of the specific T4SS - as reported for translocation 108 
of MobA of plasmid RSF1010 by the VirB T4SS of Agrobacterium tumefaciens (14) -, or 109 
upon addition of the corresponding secretion signal, as done with TraA of plasmid 110 
pATC58 and the VirB/D4 T4SS of Bartonella henselae (15). Moreover, two different 111 
reports have demonstrated that relaxase-DNA complexes from two conjugative 112 
systems can be translocated into human cells through the VirB/D4 T4SS of B. henselae. 113 
Those studies reported relaxase-mediated transfer of bacterial plasmids containing the 114 
oriT and conjugative genes from Bartonella cryptic plasmid pBGR1 (16) or from 115 
conjugative plasmid R388 (17). For both relaxases, the addition of a BID domain, the 116 
translocation signal for the Bartonella VirB/D4 T4SS (15), increases DNA transfer (16, 117 
18). These reports suggest that trans-kingdom DNA transfer may naturally occur during 118 
bacterial infection of human cells.  119 
T4SS-mediated DNA transfer to human cells may have biotechnological 120 
applications as a tool for in vivo DNA delivery into specific human cells (19). A main 121 
concern in genetic modification protocols is the fate of the introduced foreign DNA in 122 
the cells. Schröder and co-workers found that the relaxase-driven DNA integrated into 123 
the human genome at low frequency, and characterized several integration sites 124 
demonstrating that pBGR1 Mob relaxase can protect the 5´end of the mobilizable 125 
plasmid, but no preference for specific integration sites could be identified, suggesting 126 
random integration of the incoming DNA (16). 127 
 In contrast to Mob, TrwC has site-specific integrase activity in bacteria, 128 
conferring added potential as a tool for genomic engineering (20). In this work, we 129 
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analyze TrwC integrase activity into human genomic DNA after the mobilization of 130 
TrwC-DNA complexes from B. henselae. We show evidence that TrwC is active in the 131 
human cell, although the efficiency of site-specific integration is negligible compared 132 
to random integration. Interestingly, we find that TrwC promotes a 100-fold increase in 133 
the efficiency of integration of the incoming DNA, suggesting it may be protecting DNA 134 
from degradation; this feature could be combined with the action of a site-specific 135 
nuclease for genomic engineering purposes.  136 
 137 
  138 
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MATERIALS AND METHODS 139 
 140 
Bacterial strains and growth conditions. Escherichia coli strain D1210 (21) was 141 
used for DNA manipulations, while strain β2163 (22) was used as donor for conjugative 142 
matings to B. henselae. E. coli strains were grown at 37ºC in Luria-Bertani broth, 143 
supplemented with agar for growth on plates. B. henselae strain RSE247 (23) was used 144 
for the infection of human cells. B. henselae was grown on Columbia blood agar (CBA) 145 
plates at 37°C under 5% CO2 atmosphere. For selection, antibiotics were added at the 146 
indicated concentrations: ampicillin (Ap), 100 μg/ml; kanamycin monosulphate (Km), 147 
50 μg/ml; streptomycin (Sm), 300 μg/ml (E. coli) or 100 μg/ml (B. henselae); 148 
gentamicin sulphate (Gm), 10 μg/ml. When needed, media were supplemented with 149 
diaminopimelic acid (DAP) at 0.3 mM. 150 
Plasmids. Bacterial plasmids are listed in Table 1. Plasmids were constructed 151 
using standard methodological techniques (24). Primers used in plasmid constructions 152 
are listed in Table 2. Plasmids pCOR31, 33, and 35 were constructed by cloning a 153 
neomycin resistance cassette amplified from pRS56 with primers adding ClaI restriction 154 
sites (Table 2) into the same site of pHP159, pLA24, and pHP181, respectively. Plasmids 155 
pMTX708 and 709 were constructed by cloning a Ptac-oriT cassette into the NotI site of 156 
pTRE2hyg vector, selecting both orientations; Ptac-oriT was amplified from plasmid 157 
pOD1, which carries an EcoRI-HindIII fragment from pSU1186 (25) containing R388 oriT 158 
into the same sites of expression vector pKK223-3 (Pharmacia). Restriction enzymes, 159 
shrimp alkaline phosphatase, and T4 DNA ligase were purchased from Thermo-Fisher 160 
Scientific. Kapa HiFi DNA polymerase was purchased from Kapa Biosystems. Plasmid 161 
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DNA was extracted using GenElute Plasmid Miniprep Kit (Sigma Aldrich). DNA 162 
sequence of all cloned PCR fragments was determined.  163 
Mating assays. Plasmids were routinely introduced in B. henselae by 164 
conjugation. E. coli donor strain was grown in LB to stationary phase. 200 μl were 165 
collected for each mating and resuspended in 1 ml of PBS. Recipient B. henselae was 166 
grown in CBA plates for 3-4 days. After that time, bacteria from half of the plate were 167 
collected with a cotton swab and resuspended in 1 ml of PBS. Both donor and recipient 168 
aliquots were centrifuged, pellets were resuspended in 20 μl of PBS, mixed, and the 169 
mixture was placed on a cellulose acetate filter on a CBA plate supplemented with 170 
DAP. The mating plate was incubated at 37ºC in a 5 % CO2 atmosphere during 6 h. 171 
Transconjugants were selected by recovering the mating mixture and streaking it on a 172 
CBA plate with appropriate antibiotics. The plate was incubated for 6-9 days at 37ºC in 173 
a 5 % CO2 atmosphere. 174 
Cell lines and growth conditions. Human cell lines used in this work were 175 
immortalized hybridoma EA.hy926 (ATCC CRL-2922), a fusion cell line of human 176 
umbilical vein endothelial cells (HUVEC) and adenocarcinomic human alveolar basal 177 
epithelial cells (A549), and HeLa (ATCC CCL-2), epithelial cells of cervix 178 
adenocarcinoma. HeLa cells containing an integrated copy of the R388 oriT were 179 
created by transfection of plasmids pMTX708/9 (Table 1) and selection of stable 180 
transfectants as explained in the next section. 181 
Cell lines were routinely grown in DMEM medium (Lonza) supplemented with 182 
FBS 10 % (Lonza) at 37ºC under 5 % CO2. When indicated, antibiotics were added to 183 
the medium at the following concentrations: G418 disulfate salt (Sigma Aldrich), 500 184 
μg/ml; hygromycin B (Invitrogen), 80 μg/ml; penicillin-streptomycin 1 % (Lonza).  185 
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Transfections. HeLa cells were transfected with the cationic JetPei transfection 186 
reagent (Polyplus Transfection). The amounts of DNA and JetPei reagent were adjusted 187 
depending on the cell culture format used, following the manufacturer´s instructions. 188 
DNA was quantified using a Nano-Drop Spectrophotometer ND-1000 (Thermo 189 
Scientific). To generate stably transfected cell lines, HeLa cells were allowed to grow 190 
and to express the drug resistance gene under non-selective conditions for 24-48 191 
hours after transfection. Then, cells were cultivated in standard medium 192 
supplemented with the appropriate drug during 4-5 weeks, until outgrowth of 193 
resistant cells. Medium was changed every 2-3 days to avoid loss of selection pressure. 194 
To obtain the integration rate of transfected plasmid DNA, transfections were carried 195 
out in 6-well plates. To transfect linearized DNA, plasmid DNA was digested with 196 
Alw44I (Thermo Scientific) and purified with GeneJet Gel Extraction kit (Thermo 197 
Scientific) prior to transfection.  198 
Cell infections. B. henselae containing the appropriate plasmids were grown on 199 
CBA plates for 3-4 days. Human cells were seeded the day before the infection. For 200 
routine infections, cells were seeded in 6-well plates (80,000 cells per well) in 3 ml of 201 
medium. When the purpose of the infection was to select human cells that had stably 202 
acquired the plasmid transferred from B. henselae, infections were performed in 150 203 
mm tissue culture dishes seeded with 1.2x106 cells in 20 ml of medium.  204 
The day of infection, DMEM was replaced by M199 medium (Gibco) 205 
supplemented with FBS 10 % and appropriate antibiotics to select for the B. henselae 206 
strains to be added. The bacteria were recovered from the CBA plate and resuspended 207 
in 1 ml of PBS. The number of bacteria was calculated considering that an OD600=1 208 
corresponds to 109 bacteria/ml (26). Bacteria were added to the human cells to get a 209 
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multiplicity of infection (MOI) of 400. The mixture of human cells and bacteria was 210 
incubated for 72 hours at 37ºC under 5 % CO2.  211 
Detection of GFP-positive cells. At 72 hours post infection (hpi), infected cells 212 
were washed with PBS, trypsinized, and analyzed by flow cytometry using a Cytomics 213 
FC500 flow cytometer (Beckman Coulter). Uninfected cells were always used in parallel 214 
to set the baseline for detection of GFP-positive cells 215 
Selection of stable integration events. At 72 hpi, G418 disulfate salt (Sigma 216 
Aldrich) was added to infected cells, and selection was maintained for 4-5 weeks. 217 
Resistant colonies were counted on the plates. G418-resistant cell pools were collected 218 
for further analysis of GFP expression and PCR analysis. Genomic high molecular 219 
weight DNA was extracted using High Pure PCR Template Preparation Kit (Roche). 220 
Linear amplification mediated PCR. Amplification of genomic integration sites 221 
by linear amplification mediated PCR (LAM-PCR) was performed as described in (27). 222 
Briefly, it consists of an initial linear amplification of genome-plasmid junctions with a 223 
plasmid-specific primer. After synthesis of dsDNA, the PCR product is cut with a 224 
restriction enzyme (BfaI or Tsp509I) and a linker cassette of known sequence is ligated. 225 
Exponential PCR amplifications are then performed with plasmid- and linker-specific 226 
primers. PCR-obtained bands are then analyzed by gel electrophoresis and high-227 
throughput sequencing. Human genomic DNA from human blood (buffy coat; Roche) 228 
was analyzed in parallel as negative control. 229 
LAM-PCR template was genomic DNA from the G418-resistant pools. PCR 230 
reactions were carried out using Taq DNA polymerase (Genaxxon Bioscience). HPLC-231 
purified primers (Table 2) were designed using Primer3Plus software and ordered from 232 
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Eurofins Genomics. Details on the primers can be found in supplemental Materials 233 
and Methods and Fig. S1. 234 
High-throughput sequencing of LAM-PCR products. DNA sequence of purified 235 
LAM-PCR products was determined using MiSeq Benchtop next generation sequencing 236 
technology (Illumina). The appropriate volumes of different purified samples were 237 
mixed together following the manufacturer´s recommendations. Primers used in the 238 
second exponential amplification contained the adaptor sequences needed for the 239 
sequencing reaction (PE-PCR 1.0 and 2.0, see Table 2). LAM-PCR products were 240 
sequenced in both directions. From PE-PCR 1.0 (adaptor present in the primer 241 
annealing to the plasmid sequence) 400 nt were sequenced, while only 50 nt were 242 
sequenced from PE-PCR 2.0 (adaptor present in the primer annealing to the linker). 243 
Information from PE-PCR 1.0 was used for sorting the sequences to the different 244 
samples and integration site detection, while information obtained from PE-PCR 2.0 245 
was used only for sorting. 246 
Bioinformatic analysis to obtain the integration sites was performed by high-247 
throughput insertion site analysis pipeline (HISAP) (28). Briefly, sequences were 248 
trimmed by identification and removal of plasmid- and linker-specific sequences. 249 
Genomic sequences were aligned to the human genome using stand-alone BLAT 250 
(UCSC), using assembly GRCh37/hg19 as reference. Sequences with identities lower 251 
than 95% were discarded. For each remaining sequence, the chromosome, the 252 
integration site, and the nearest RefSeq protein-coding gene were recorded. 253 
Detection of oriT-specific integration events by PCR. PCR reactions were 254 
carried out using Kapa Taq Polymerase (Kapa Biosystems) following manufacturer´s 255 
recommendations. 25 ng of plasmid DNA or 250 ng of genomic samples were used as 256 
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template. To detect the expected cointegrate molecule, primers NotI_Ptac and 257 
Int_pCOR (Table 2) were used for initial amplification. A 1:50 dilution of the initial PCR 258 
products served as template for the secondary PCR, carried out with primers 259 
NotI_Ptac_2 and Int_pCOR_2 (Table 2), annealing approximately 80 bp closer to the 260 
expected integration junction. Primers NotI_Ptac and NotI_oriT1 (Table 2) were used 261 
to amplify the chromosomal Ptac-oriT cassette.  262 
Recovery of Integrated Plasmids. 5 μg of genomic DNA from G418-resistant 263 
cell pools were digested with XmaJI (Thermo-Fisher Scientific), which does not cleave 264 
within the integrated plasmid. Digested DNA was treated with T4 DNA ligase at a DNA 265 
concentration of 10 μg/ml, to favour self-ligation. The reaction was electroporated into 266 
ElectroMAX DH10B E. coli cells (Thermo-Fisher Scientific). Plasmid DNA was extracted 267 
from gentamicin-resistant E. coli transformants, and analyzed by PCR to narrow down 268 
the region of the plasmid where the insert of human origin was located. Primers used 269 
for PCR mapping reactions are shown in Table 2. The insert in plasmid pCOR52 was 270 
sequenced with primers pCOR33_1641F and pCOR33_12445R (Table 2). 271 
Statistical analysis. Unpaired student´s t-test was used to determine 272 
statistically significant differences between the mean of at least 3 independent results 273 
for each experiment when the data followed a normal distribution. Otherwise, a 274 
Wilcoxon-rank-sum analysis was performed for each pair of compared data. 275 
 276 





Construction of mobilizable plasmids and target cell lines. TrwC-DNA 280 
complexes can be introduced in human cell lines through the T4SS of B. henselae. In 281 
order to analyze the integration pattern of the transferred DNA upon Bartonella 282 
infection of human cells, new mobilizable plasmids and cell lines were constructed. 283 
The mobilizable plasmids previously used to test DNA transfer from B. henselae to 284 
human cells (17) contained elements of the R388 Dtr region (oriT+trwABC), but not the 285 
genes of the T4SS, and a eukaryotic gfp expression cassette. We added a neomycin 286 
phosphotransferase eukaryotic expression cassette in order to be able to select for 287 
stable chromosomal integration events. Plasmids were constructed coding for either 288 
TrwC or TrwC:BID (TrwC with the secretion signal for Bartonella VirB/D4 T4SS fused to 289 
its C terminus), and a negative control lacking trwC. Plasmid pRS130 (16) encoding 290 
Mob:BID relaxase and its cognate oriT was always tested in parallel. 291 
The cell lines used for Bartonella infections were EA.hy926 and HeLa. The 292 
former is derived from fusion of A549 lung carcinoma cells with human vascular 293 
endothelial cells, the latter representing the natural target for Bartonella, and is 294 
efficiently infected by this bacterium (29). HeLa cells represent a cervix-derived 295 
epithelial cells line that can be easily manipulated by cell biological and genetic 296 
methods and infection by B. henselae was reported to occur with 50% efficiency (30). 297 
We previously showed DNA transfer to EA.hy cells, but HeLa cells were not tested. 298 
EA.hy926 and HeLa cells were tested in parallel in infections with B. henselae carrying 299 
either pHP161 (oriT+trwABC) or pHP181 (oriT+trwAB). DNA transfer efficiency was 300 
15 
 
lower when using HeLa than when using EA.hy926 cells, but it can be detected robustly 301 
in both cell lines (Fig. 1). 302 
In order to compare frequencies of TrwC-mediated integration into natural 303 
sequences of the human genome with integration when the TrwC target is present in 304 
the recipient cell genome, a cell line containing a full length wild-type oriT was 305 
constructed. We transfected both EA.hy926 and HeLa cells with plasmids pMTX708 306 
and pMTX709 (Table 1), carrying a hygromycin-resistance gene and the R388 oriT in 307 
both orientations. Both plasmids were used to avoid any bias due to eukaryotic 308 
promoters present in the vector, since transcription through the oriT has been shown 309 
to affect TrwC-mediated recombination (11), and so it could affect integration. Around 310 
100 hygromycin-resistant colonies were obtained in transfections of HeLa cells, while 311 
no transfectants appeared for EA.hy926 in spite of several attempts with up to 5 μg of 312 
plasmid DNA. Consistent with this finding EA.hy926 cell line has been previously 313 
reported to be difficult to transfect (30, 31). 314 
The hygromycin-resistant HeLa colonies obtained were pooled together to 315 
establish a polyclonal HeLa::oriT cell line, in which the oriT is expected to be located in 316 
different chromosomal locations and in the two possible orientations with respect to 317 
the vector promoter. In this way, we avoid selecting a single clone in which the oriT 318 
copy may lie in a chromosomal region that could affect integration of the mobilizable 319 
plasmid. The presence of the oriT was tested by PCR on genomic DNA samples from 320 
HeLa and HeLa::oriT cells using primers oriT1 and oriT330 (Table 2). Only one band 321 
corresponding to the oriT was present in the sample obtained from HeLa::oriT cells, 322 




Transient and permanent expression of transferred DNA in human cells. In 325 
order to measure transfer and integration rates of DNA molecules led by different 326 
relaxases into human cells, gfp and neo-resistance gene expression were measured 327 
respectively, as outlined in Fig. 2a. EA.hy926, HeLa and HeLa::oriT cell lines were 328 
infected with B. henselae carrying pCOR31 (trwC), pCOR33 (trwC:BID), pCOR35 (ΔtrwC) 329 
or pRS130 (mob:BID) mobilizable plasmids. Results are shown in Fig. 2 and Table S2. 330 
Three days post infection, gfp expression was measured by flow cytometry (Fig. 2b). 331 
DNA transfer occurred to the three different cell lines when a relaxase (TrwC, 332 
TrwC:BID, or Mob:BID) was coded in the plasmid, while no DNA transfer was detected 333 
when there was no relaxase. The transfer efficiency is higher when using EA.hy926 as 334 
host cell, as previously shown (Fig. 1). No significant differences were found in DNA 335 
transfer between HeLa and HeLa::oriT cell lines, as expected. In all cell lines, DNA 336 
transfer rate was significantly lower when using Mob:BID relaxase compared to TrwC 337 
or TrwC:BID.  338 
Integration events of the transferred plasmids into the human genome were 339 
selected by antibiotic treatment with G418. The drug was added at 72 hpi and 340 
selection was maintained for 4-5 weeks. The resistant colonies obtained for each 341 
experimental condition were counted and then pooled together. High molecular 342 
weight genomic DNA preparations were analyzed by PCR for the presence of trwA and 343 
trwC to confirm the presence of the integrated plasmid (Fig. S3). The resistant cell 344 
pools were also analyzed by flow cytometry to detect GFP expression as another 345 
evidence of integration of the mobilizable plasmids (Fig. S4). 346 
Fig. 2c shows the number of resistant colonies obtained after the antibiotic 347 
treatment, normalized to the number of cells at the beginning of the experiment. It 348 
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was lower when using EA.hy926 than when using HeLa cells, despite the fact that DNA 349 
transfer was up to 10-fold higher with EA.hy926. For all cell lines, no resistant colonies 350 
were found when using ΔtrwC plasmid, in concordance with the flow cytometry 351 
results, which showed no DNA transfer in the absence of relaxase. When plasmids 352 
coded for a relaxase, resistant colonies appeared, but at drastically different rates. 353 
Thousands of resistant colonies were obtained in each experiment after mobilization 354 
of trwC- and trwC:BID-carrying plasmids, while only up to 100 resistant colonies were 355 
found in infections with B. henselae carrying the plasmid coding for Mob:BID (see 356 
Table S2). 357 
Fig. 2d shows the ratio between NeoR colonies and GFP+ cells, which gives the 358 
integration rate, i.e. the proportion of cells receiving the DNA in the nucleus which 359 
integrate this DNA into the chromosome. For each cell line, no significant differences 360 
were found in the integration rate of TrwC or TrwC:BID plasmids, as expected. No 361 
significant differences were found either in the integration rate of each plasmid in 362 
HeLa and HeLa::oriT cells. The integration rate was higher than 1 in 20 when the 363 
transferred DNA was led by TrwC or TrwC:BID, while it was around 1 in 250 in the case 364 
of Mob:BID-driven DNA (Table S2). 365 
With the purpose of having a parallel control of random integration, HeLa and 366 
HeLa::oriT cells were transfected with plasmid pCOR35 (ΔtrwC). Transient vs. stable 367 
expression was determined as outlined before. After transfection of plasmid DNA, we 368 
obtained an integration rate of around 1 in 800 when transfecting supercoiled DNA 369 
and of close to 1 in 300 when transfecting linearized DNA (Table S2), which is in the 370 
range of aour data obtained for Mob-BID. Antibiotic resistant colonies were pooled 371 
18 
 
together and analyzed in parallel with those obtained after relaxase-mediated 372 
mobilization of plasmid DNA, to compare both plasmid integration patterns.  373 
Characterization of genomic integration sites. Relaxases transfer the DNA 374 
strand covalently linked to a site known as the nic site. In the case of Mob-led DNA, it 375 
has been suggested that the relaxase protects the 5´end of this DNA (16). In addition, 376 
we know that TrwC acts as a site-specific integrase of the transferred DNA into the 377 
genome of recipient bacteria (12), and we observed enhanced integration rate of 378 
TrwC-led DNA. Taking together these evidences, we decided to search for integration 379 
events occurring at the nic site of the R388 oriT. For this purpose, we used linear 380 
amplification-mediated PCR (LAM-PCR) (32, 33) using a primer annealing close to the 381 
nic site, as explained in Fig. S1. This strategy would not detect insertions into the full-382 
length oriT copy of HeLa::oriT, as integration would result in a reconstituted oriT, but it 383 
would allow the identification of integration events in other chromosomal locations, 384 
and comparison with the integration pattern obtained when the oriT is not present in 385 
the genome to be modified. 386 
LAM-PCR was performed as explained in Materials and Methods and 387 
supplemental Material and Methods sections. Genomic DNA was extracted from pools 388 
of several thousands of resistant colonies obtained after mobilization of trwC- or 389 
trwC:BID-coding plasmids, and this DNA was used as template for the PCR reactions. 390 
Genomic DNA was also extracted from resistant colonies obtained by transfection of 391 
plasmids pCOR31 (trwC) and pCOR33 (trwC:BID), which are expected to have a random 392 
integration pattern. After LAM-PCR amplification of the integration junctions, two 393 
different restriction enzymes were used to avoid any bias due to restriction fragment 394 
size. PCR products were checked by electrophoresis in agarose gels (Fig. 3).  395 
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Fig. 3a-c shows the scheme of the expected band sizes observed in these gels.  396 
We expected to see as many bands as different integration sites occurring at the nic 397 
site (Fig.3a), depending on the location of the nearest restriction site in the genomic 398 
junction. If integration did not occur at the nic site, the size of the band would be 399 
determined by the nearest recognition site in the integrated plasmid (220 bp when 400 
using BfaI and 580 bp when using Tsp509I, since this does not cut in the oriT but in 401 
trwA; Fig 3b). In the case of the HeLa::oriT cell line, which has an oriT copy integrated 402 
in the genome, we expected to obtain in all cases a major band of 220 bp (BfaI) or 345 403 
bp (Tsp509I) corresponding to the sequence of the oriT-carrying integrated plasmid 404 
(Fig 3c).  405 
As it can be observed in Fig. 3d, a single band was obtained from all samples, 406 
obtained either after plasmid transfection or after translocation of TrwC(:BID)-DNA 407 
molecules through B. henselae T4SS. The size of the band was in all cases the expected 408 
for the full length oriT present in the mobilizable plasmids or in the genomic oriT copy, 409 
as explained above and in Fig 3a-c. For the G418-resistant pools obtained either after 410 
transfection or infection of HeLa::oriT cells, both 345 bp and 580 bp would be visible 411 
when using Tsp509I, as observed in the sample obtained after infection and DNA 412 
transfer mediated by TrwC (Fig. 3d bottom gel, line 6). A reason for this not being the 413 
case for the other samples could be that the smaller amplicon could be preferentially 414 
amplified. 415 
These results strongly suggest that the transferred DNA had not become 416 
integrated by the nic site at the oriT. Rather, they presumably reflect illegitimate 417 
integration events. Since low-frequency site-specific integration events could be 418 
masked by this main band, LAM-PCR products were thus analyzed by high-throughput 419 
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sequencing, as explained in Materials and Methods. After identification of linker- and 420 
plasmid-specific sequences, the flanked sequences were characterized. As expected 421 
from the results in Fig. 3d, most of the 2,000,000 reads obtained were found to be 422 
plasmid DNA. This confirms that most of the DNA entering the human cell covalently 423 
linked to TrwC is not integrated at the nic site, implying that this DNA is recircularized 424 
prior to integration. 425 
 There were 11,317 reads which could be mapped to the human genome. To 426 
discard false positives, identity to the human genome threshold was raised to 98% and 427 
integration events obtained less than 15 times were not considered. The resulting 9 428 
integration events (IE) are shown in Table 3. IE1 and IE2 were found to occur at the 429 
same site of the human genome (the differences in the sequencing reads were 430 
assumed to be sequencing errors) so they were considered together as one integration 431 
event and named IE2. Most of the integration events showed more than 12 missing 432 
base pairs of a total of 41 bp amplified from primer oriTI binding site to the nic site, so 433 
they were considered as random integration events. 434 
There were only two IE which were not missing any oriT sequence 3’ to the nic 435 
site. When aligned with the human DNA sequence, it was found that integration in IE2 436 
had occurred at the position nic+1, since this base from the oriT sequence was present 437 
at the junction and is not present in the UCSC genomic sequence used as reference. 438 
We confirmed the genomic sequence of this position in the genome of the HeLa cells 439 
used in the experiment, by amplification of the chromosomal region around the 440 
integration site (IS) IS2 with primers IS2_Hu11 and Xba_IS2_Hu11 (Table 2) and 441 
sequencing the PCR product with the former primer, and this base pair was not 442 
present there either. Considering the high specificity of conjugative relaxases for 443 
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nicking exactly at their nic site, this result suggests that this event was yet another 444 
illegitimate integration event. Finally, IE7 occurred exactly at the nic site, and 445 
moreover, the eight nucleotides of the human genome 5’ to the integration site are 446 
identical to the eight nucleotides 5’ to the nic site in R388 oriT (Fig. 4). This integration 447 
event took place 1,352,133 bp downstream of the SLITRK1 gene (NM_052910) in 448 
human chromosome 13. 449 
As LAM-PCR did not allow the detection of the integration events occurring at 450 
the oriT copy present in the chromosome of HeLa::oriT cells, we tried to detect them 451 
by PCR amplification of the expected cointegrate molecule; we used a primer 452 
annealing in the Ptac promoter located adjacent to the chromosomal oriT copy, and 453 
another one annealing in the mobilizable plasmid (Table 2). As a control, the 454 
chromosomal Ptac-oriT cassette was amplified in the same samples analyzed; as 455 
expected, the cassette was detected in HeLa::oriT and the G418-resistant pools 456 
obtained with this cell line, while no amplification was obtained in HeLa and HeLa-457 
derived cell pools. The PCR to amplify the oriT-oriT cointegrate was negative (data not 458 
shown), even after a second round of PCR amplification. Although we cannot discard 459 
oriT-specific integration occurring at such low frequency that it is not detectable by 460 
PCR, this results indicates that it is not occurring efficiently. 461 
LAM-PCR can only be used to map those integration events that occurred by a 462 
known sequence of the transferred DNA (the nic site in our case), but most of the 463 
plasmid molecules became integrated in a nic-independent manner. Out of the 8 464 
human genomic junctions obtained by LAM-PCR (Table 3), 7 did not occur by the nic 465 
site, and so they represent random integration events. However, they provide 466 
information on only one of the integration junctions of the plasmid. We attempted to 467 
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characterize other random integration sites by recovery of the integrated plasmids 468 
together with the flanking genomic sequences, as outlined in Materials and Methods. 469 
With this strategy, we were able to characterize one integration event and its 470 
corresponding plasmid-genomic DNA junctions (Fig. 5). We determined that only a 471 
fragment of the plasmid was integrated, which does not include the neomycin 472 
resistance gene, so most probably there is another integration event somewhere else 473 
in that same cell coding for the neoR gene. We also observed that both genomic-474 
plasmid DNA junctions did not occur at the same position of the human genome. 475 
Moreover, near one of the junctions (IJ-B in Fig. 5b), a genomic rearrangement was 476 
found, when compared to the reference genome (see coordinates in Fig. 5b). The 477 
reason could be that the genomic region of chromosome 15 where integration 478 
occurred corresponds to a copy of L1MC2, a long interspersed element (LINE), often 479 
associated with genomic rearrangements and deletions (34). We tried to sequence 480 
that region from genomic DNA of the HeLa cell line used in the experiment using 481 
primer Chr15_88728 (Table 2), to determine if the rearrangement was already present 482 
or it was a consequence of the illegitimate integration event, but mixed sequences 483 
were always obtained. 484 
The genomic integration sites of all random integration events characterized 485 
were aligned with the R388 nic region at the oriT (Table 4). No homology with the oriT 486 
was detected, supporting the idea of illegitimate integration. 487 





The ability to deliver DNA into specific human cell types and to promote its 491 
integration in the human genome has high potential as biotechnological tool. In 492 
particular, gene therapy strategies ideally should grant in vivo access to specific human 493 
tissues and permanent expression of the introduced DNA. In this work, we explore the 494 
potential of a bacterial system for genomic modification of the human genome. Our 495 
previous work showed that the substrate of a conjugative plasmid, the TrwC-DNA 496 
complex, was delivered efficiently to human cells through the T4SS of B. henselae (17); 497 
the many advantages of such a DNA delivery system in this context have been already 498 
discussed (19). We previously showed in a bacterial system that TrwC could catalyze 499 
integration of the transferred DNA into DNA sequences of human origin (12), so we 500 
aimed to evaluate its potential role as a site-specific integrase in human cells, which 501 
would complement the DNA delivery tool. We have analyzed the fate of the DNA in the 502 
human cells after translocation as a TrwC-DNA complex through the VirB/D4 T4SS of B. 503 
henselae.  504 
We measured the efficiency of DNA delivery and integration by the two 505 
relaxases previously described to deliver DNA through the T4SS VirB/D4 of B. henselae, 506 
TrwC and Mob:BID. All mobilizable plasmids carried a eukaryotic expression GFP 507 
cassette, allowing us to estimate the efficiency of DNA transfer by measuring the 508 
percentage of GFP positive cells. This assay probably underestimates the percentage of 509 
cells receiving DNA, since this DNA has to get into the nucleus and be converted into 510 
double-stranded form so that it can express the GFP gene. Thus, nuclear localization of 511 
the relaxase could affect DNA transfer rates. TrwC has been reported to have 512 
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cytoplasmic localization (35) while a passive entry of the Mob-guided DNA has been 513 
suggested (16), so none of the relaxases is expected to have an active role in nuclear 514 
import.  515 
Our results show that DNA transfer is higher when using TrwC compared to 516 
Mob:BID. The differences in DNA transfer rates are probably due to differences in T4SS 517 
recruitment efficiency for each relaxase. TrwC could be naturally a better substrate for 518 
the B. henselae VirB/D4 T4SS than Mob:BID. There is another important factor to take 519 
into account: the mobilizable plasmids enconding trwC also code for R388 proteins 520 
TrwA and TrwB, which could play a role in substrate recruitment. Deletion of trwB was 521 
shown to affect the transfer of TrwC-DNA complexes significantly (17). Thus, it is likely 522 
that TrwB enhances recruitment of TrwC by the VirB/D4 T4SS independently of BID, as 523 
previously suggested (16, 18). 524 
The plasmids mobilized to human cells carried a eukaryotic resistance marker 525 
to select for stable integration events by antibiotic treatment. Selection was carried 526 
out for four weeks, discarding the possibility of episomal persistence of the transferred 527 
plasmid DNA. Each resistant colony was counted as one integration event. Again, this 528 
measure is an underestimation of the integration rate. One single colony could harbor 529 
more than one integration event; in fact, the only integration event mapped in its 530 
extension (the rescued integrated plasmid) did not include the neoR region (Fig. 5a), 531 
implying this gene must be integrated somewhere else in the genome. In addition, not 532 
all cells integrating the plasmid will thrive to render a colony. This phenomenon was 533 
particularly evident with Ea.hy926 cells, which have low viability. Consequently, we 534 
obtained less resistant colonies when using EA.hy926 than when using sturdy HeLa 535 
cells, despite the fact that DNA transfer was up to 10-fold higher with EA.hy926 (Fig. 536 
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2). Of course, we cannot rule out that the different integration rates observed in both 537 
cell lines are due to intrinsic differences affecting host-mediated integration of foreign 538 
DNA. 539 
The number of integration events obtained for each experiment was 25-158 540 
times higher when either TrwC or TrwC:BID were present, compared to Mob:BID 541 
(Table S2). When we measured integration rates, as number of resistant colonies 542 
normalized to the number of cells expressing the transferred DNA, we observed that 543 
the integration rate for TrwC was on average 1 in 20, while for Mob:BID it went down 544 
to about 1 in 250, similar to the integration rate obtained for transfected cells (Fig. 2d 545 
and Table S2). Thus, we conclude that TrwC facilitates the integration of the 546 
mobilizable plasmids, while Mob does not.  547 
A plausible explanation for this difference could be the site-specific integration 548 
activity of TrwC, which is presumably absent in the Mob relaxase. To test this 549 
hypothesis, we analyzed the integration pattern in the human genome, searching for 550 
TrwC-mediated site-specific integration events. Their signature would be the precise 551 
integration of the R388 nic site into human DNA sequences resembling the natural 552 
TrwC target. We analyzed genomic DNA of the resistant cell pools by LAM-PCR, 553 
priming from the plasmid DNA into the nic site, and subsequent DNA sequencing. The 554 
results showed the presence of intact oriT sequences in the vast majority of the 555 
sequencing reads. One possible explanation could be the integration of plasmid 556 
concatemers, as it happens in the integration of T-DNA mediated by A. tumefaciens 557 
(36), but then oriT-host genome junctions would be detected at the end of the 558 
concatemer. The DNA extraction kit isolates high molecular weight DNA (30-50 kb) 559 
from mammalian cells, while bacterial cells are not lysed, discarding the possibility that 560 
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plasmid DNA of bacterial origin could be co-isolated. In addition, the absence of 561 
transformants when using the same DNA preparations for plasmid rescue (a single 562 
transformant was obtained, originated from a rescued integrated plasmid copy) rules 563 
out the presence of episomal plasmid molecules. Thus, the most likely possibility is 564 
that these reads represent random integration events of the plasmid, which would 565 
have been recircularized previously, since it enters the human cell cut at the nic site 566 
(where TrwC is covalently bound). Recircularization implies that TrwC is active in the 567 
human recipient cell, mimicking its activity in the bacterial recipient cell during 568 
conjugation (37).  569 
Out of the thousands of different integration events present in the analyzed cell 570 
pools, we detected one putative site-specific integration event (IE7). It occurred 571 
precisely at the nic site and in a region of the genome showing 8 base pairs identity 572 
with the oriT at the 5´ end of the nic site (Fig. 4). Since the probability of integration at 573 
any position of the human genome is approximately 1/3x109, and the probability of 574 
integration occurring by the nic site is less than 1/1x104 (the size of the integrated 575 
plasmids is around 13 kb), the probability that this event occurred randomly is 576 
negligible. From our results we infer that TrwC can act as a site-specific integrase in 577 
human cells, but host-mediated random integration is at least 3-4 logs more efficient. 578 
Thus, after TrwC-mediated recircularization of the DNA (as inferred from the presence 579 
of full-length oriTs), most molecules would undergo non-homologous integration 580 
events, as observed in the characterized integration sites (Table 4).  581 
DNA can also be delivered into human cells by the relaxases Mob and A. 582 
tumefaciens VirD2, and it integrates randomly in the genome (16, 38). It was proposed 583 
that these relaxases do not play a role in the integration process, which is likely 584 
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mediated by the host machinery, but do protect the 5´end of the transferred DNA, 585 
based on preservation of the 5´end region of the transferred DNA molecules (16, 38). 586 
In our case, we found by LAM-PCR seven integration events occurring within 20 bp 587 
from the nic site (Table 3). By chance, we would expect around 30 integration events 588 
lying in a 20 nt region, from about 20,000 total integration events analyzed, so TrwC 589 
does not seem to protect the 5’ end of the transferred DNA, but rather to catalyse its 590 
conversion to a circular form. Recircularized plasmid DNA will be a more resistant 591 
molecular species, showing long-term presence in the nucleus, which could favour its 592 
subsequent random integration by the host machinery.  593 
 From a biotechnological point of view, our results indicate that TrwC is not 594 
useful as a site-specific integrase in human cells. However, with the introduction of 595 
precision genome editing using RNA-guided endonucleases, such as Cas9 (39), we have 596 
entered a new era of genetic engineering and gene therapy which is leaving obsolete 597 
the traditional site-specific recombinases and nucleases used for gene targeting in 598 
human cells (40). In this new scenario, an improvement in CRISPR-Cas technology 599 
would have an immediate impact in the human gene editing field. An RNA-guided 600 
nuclease could be translocated simultaneously with TrwC-DNA through the T4SS of 601 
bacteria that infect specific human cell types. Delivery of the nuclease protein instead 602 
of transfecting the gene could avoid toxicity and off-target activity. The effect of TrwC 603 
as DNA chaperone in combination with a site-specific nuclease would promote 604 
integration of the incoming DNA molecule by homologous recombination. In support 605 
of this approach, it has been reported that concomitant translocation of I-SceI homing 606 
site-specific endonuclease together with VirD2 relaxase-T-DNA complexes through A. 607 
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tumefaciens T4SS enhanced T-DNA site-specific integration into the yeast chromosome 608 
when the I-SceI target site was present (41).  609 
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FIGURE LEGENDS 756 
 757 
Fig. 1. DNA transfer to EA.hy926 and HeLa cell lines. The graph shows the 758 
percentage of GFP positive cells detected after 3 days of infection. The cell lines 759 
indicated in the x axis were infected with B. henselae carrying the mobilizable plasmids 760 
pHP181 (containing R388 oriT+trwAB) or pHP161 (coding for R388 oriT+trwABC); this is 761 
indicated as AB or ABC, respectively. Data are the mean of at least 5 independent 762 
experiments. **, p<0.01.  763 
Fig. 2. Transient and permanent expression of the transferred DNA. a) Overview 764 
of the experimental design to detect transient expression or stable integration of the 765 
transferred DNA. After infection of human cell lines with B. henselae, the DNA 766 
transferred through the T4SS will get to the nucleus where genes will be expressed. At 767 
3 days post infection, transient expression of gfp can be detected by flow cytometry. 768 
Antibiotic treatment was applied for long-term selection of neomycin-resistant 769 
colonies, to detect stable integration events. b), c) and d) Graphical representation of 770 
the percentage of GFP-positive cells obtained 3 days post infection (b) and the number 771 
of G418-resistant colonies normalized for the number of cells at the beginning of the 772 
selection (c), as well as the NeoR/GFP+ ratio (d). The different bars represented for 773 
each cell line correspond to the different relaxases under study, following the color 774 
code indicated in the squares at the top right. Data represent the mean of at least 3 775 
independent experiments. *, p<0,05. 776 
Fig. 3. Analysis of LAM-PCR products. a-c), Scheme of the expected integration 777 
events and the subsequent LAM-PCR products. a) If integration takes place by the 5´ 778 
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end of the nic site, the size of the LAM-PCR would be determined by the distance to 779 
the nearest restriction site in the human genome (in pink). Each integration event 780 
occurring in a different locus would generate a band of a different size. The nicked oriT 781 
is indicated by a slash. b) If the plasmid becomes integrated at any other region than 782 
the nic site, the size of the LAM-PCR product would be always the same and would be 783 
determined by the distance to the restriction site in the plasmid sequence. c) In 784 
HeLa::oriT cell line, in addition to the bands generated from the integration events, the 785 
oriT copy present in pMTX708/9 plasmid generates a single band of a size determined 786 
by the distance to the restriction site in the plasmid sequence. trw has been omitted 787 
from trwA, trwB, and trwC for clarity. Bfa, BfaI. Tsp, Tsp509I. d) Gel electrophoresis of 788 
LAM-PCR products obtained when using BfaI (top gel) or Tsp509I (bottom gel) 789 
restriction enzymes. The cell line is indicated in the top row (EA, EA.hy926; He, HeLa; 790 
He:oriT, HeLa::oriT). Inf, samples obtained after Bartonella infection. Tr, samples 791 
obtained by transfection of plasmid DNA. LD, 100 bp ladder. T, trwC-coding plasmid 792 
(pCOR31). T:B, trwC:BID-coding plasmid (pCOR33).  EA, He, and He::oriT, samples from 793 
uninfected cell lines. g, Human genomic DNA (Roche), used as negative control. - 794 
(1,2,3), negative controls (no DNA) of linear, first, and second exponential PCRs, 795 
respectively. The arrows indicate the bands of the expected size according to Fig. 3b 796 
(black arrows) and 3c (blue arrow). 797 
Fig. 4. Characterization of integration event IE7. The genome-plasmid 798 
integration junction (IJ) is aligned with the DNA sequence around the nic site (oriT, on 799 
top) and the chromosomal integration site (IS, on bottom). DNA of plasmid origin is 800 
shown in blue, and genomic DNA is shown in black. The nic site and insertion sites are 801 
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indicated by a dash. Regions of homology between the plasmid and the genomic 802 
sequences are boxed. 803 
Fig. 5. Genomic integration event characterized by recovery of the integrated 804 
plasmid. a) Scheme of the mobilizable plasmid coding for trwC:BID, and the structure 805 
of the integrant in the genomic DNA of HeLa cells. Plasmid DNA is represented as a 806 
blue horizontal line, and HeLa genomic DNA, as a black dashed line. trw is ommited 807 
from trwA, trwB and trwC:BID for clarity. The two dashes in the integrant refer to the 808 
genomic reorganization shown in b). Both plasmid-genomic DNA integration junctions 809 
resulting from the integration event are named IJ-A and -B. The DNA sequence at the 810 
junctions is shown below with their respective coordinates, in black (human genome) 811 
and blue (plasmid DNA). The junctions are highlighted in a square. Coordinates of 812 
human chromosome 15 are indicated as C-number, where the number corresponds to 813 
the coordinates of the human genome in UCSC database (assembly GRCh37/hg19). 814 
Coordinates of plasmid DNA are indicated as P-number, where the number 815 
corresponds to the nucleotide of the open reading frame of gfp (in IJ-A) or trwA (in IJ-816 
B). b) Genomic rearrangement found near IJ-A. The red dash indicates the genomic 817 






Table 1. Plasmids used in this work 822 
 823 
Plasmid Description Reference 
pCOR31 pBBR6::oriT trwABC+gfp+neo This work 
pCOR33 pBBR6::oriT trwABC:BID+gfp+neo This work 
pCOR35 pBBR6::oriT trwAB+gfp+neo This work 
pCOR52 Rescued integrated plasmid This work 
pHP159 pBBR6::oriT trwABC+gfp(a) (17) 
pHP161 pBBR6::oriT trwABC+gfp(a) (17) 
pHP181 pBBR6::oriT trwAB+gfp (17) 
pKK223-3 Expression vector Pharmacia 
pLA24 pBBR6::oriT trwABC:BID+gfp (17) 
pMTX708 pTRE2hyg::Ptac-oriT(b) This work 
pMTX709 pTRE2hyg::Ptac-oriT(b) This work 
pOD1 pKK223-3::oriT This work 
pRS56 Cre-lox+neo (15) 
pRS130 pBGR::mob:BID+gfp+neo (16) 
pSU1186 pUC8::oriT (25) 
pTRE2hyg Mammalian shuttle vector Clontech 
(a) pHP159 and pHP161 differ only in the orientation of the gfp cassette, which is in the 
same orientation as the Plac promoter in pHP161 and in the opposite in pHP159. 
(b) pMTX708/9 differ only in the orientation of the Ptac-oriT cassette. In pMTX708, the 
oriT is closer to the hygromycin resistance gene. 
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Table 2. Oligonucleotides used in this work  824 
 825 
Purpose / name Sequence (5´to 3´) 
Construction of pCOR31, 33, and 35 
mCla_SnaBI_CMV_NeoF CCAAATCGATCTACGTATTAGTCATCGCTATT 
Cla_EcoRV_NeoR CCAAATCGATGATATCCGGATATAGTTCC 
Construction of pMTX708/9 
NotI_Ptac CCAGCGGCCGCTTATCGACTGCACGG 
NotI_oriT1 CCAGCGGCCGCTCATTTTCTGCATCATTGT 

















Detection of oriT in HeLa::oriT 
oriT1 CTCATTTTCTGCATCATCA 
oriT330 CCTCTCCCGTAGTGTTA 












Mis-LC (PE-PCR 2.0)AGTGGCACAGCAGTTAGG(b) 
Mis-TrwC (PE-PCR 1.0)(N)10CGTCCTTAAAAGCCGGGTTG(c) 
oriTI CGATAACCCAATGCGCATAG 
oriTII TCTTTAGGGTCACGCTGGC 
PE-PCR 1.0 AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT 
PE-PCR 2.0 CAAGCAGAAGACGGCATACGAGATCGGTCTCGGCATTCCTGCTGAACCGCTCTTCCGATCT 







(a) (N)12, barcode sequence of linker cassette. (RO), restriction enzyme overhang. 
(b) (PE-PCR 2.0), adaptor sequences for high-throughput sequencing.  
(c) (PE-PCR 1.0), adaptor sequences for high-throughput sequencing. (N)10, barcode 
sequence introduced in second exponential PCR.  
 826 
  827 
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Table 3. Integration events characterized by LAM-PCR and DNA sequencing 828 
 829 





1 EA.hy926 TrwC 19 99.75 11 35225119 0 
2 EA.hy926 TrwC 402 100 11 35225119 0 
3 HeLa TrwC:BID 15 98,25 2 37383046 15 
4 HeLa TrwC:BID 114 100 2 111118923 16 
5 HeLa TrwC:BID 15 100 6 9173423 18 
6 HeLa TrwC:BID 84 99.48 12 28128063 16 
7 HeLa TrwC:BID 21 100 13 83099211 0 
8 HeLa TrwC:BID 95 99.72 16 68832248 16 
9 HeLa TrwC:BID 15 100 19 18303607 14 
The information collected for each integration event is shown. Number of sequences 
indicates the number of times the sequence read was found. Missing base pairs 
indicates the number of bp that are missed in the read with respect to the plasmid 
sequence until the nic site. IE, integration event. Chr, chromosome. 
  830 
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Table 4. Mapped illegitimate integration events 831 
 832 
  Integration junction 
IS     Sequence (5’-3’) Chr Genomic locus Plasmid 
2 AAAATGAGGACAGTT/ATATTTTTTAAATGT 11 35225119 nic+1 
3 CCAGATCGTGCCACT/GCATTCCAGCCTGGC 2 37383046 nic-15 
4 TGGGAAACAAATGAA/GAAACAACCCTGCTG 2 111118923 nic-16 
5 GTTTCCATGGACATT/TGCCACCCCGGCTTC 6 9173423 nic-18 
6 CGGGTTAGAAACCAA/GCACCCAAGCCGGCG 12 28128063 nic-16 
8 CACTTGCTGGGCTCA/GAGACAACCCAGCCC 16 68832248 nic-16 
9 GTTGTAACTGCCTAA/GATTGACCAACCCTA 19 18303607 nic-14 
10 GTCACATGATAAAAA/GATTATTTCATTTTG 15 60623276 gfp_73 
11 ATTTAATCCAAATAG/AAATAAGTTTCAGAT 15 60724330 trwA_353 
oriT AGGTGCGTATTGTCT/ATAGCCCAGATTTAA   nic 
The genomic integration sites are shown aligned with the wild-type target for TrwC, 
the oriT. The dash indicates the integration site (the nic site in the oriT sequence). The 
location of the integration site (Chr, chromosome number), as well as the nucleotide of 
the plasmid by which integration took place, are also displayed. IS, integration site. IS 
2-9 were characterized by LAM-PCR. IS 10 and 11 are both integration junctions of the 
event characterized by recovery of the integrated plasmid. Coordinates of genomic loci 
correspond to human genome GRCh37/hg19 available in UCSC Genome Browser. 
Plasmid coordinates refer to the distance from the nic site (+ and - indicating 5’or 3’ 
from the nic site, respectively) for IS 2-9, or the nucleotide position in the gfp and trwA 
ORFs for IS 10-11. 
 833 





